Player is loading...

Embed

Embed code

Transcriptions

Note: this content has been automatically generated.
00:00:00
So I don't know right well I in the let
00:00:04
me First tell you two things one is
00:00:06
going to happen now we were supposed to
00:00:08
have a row Well for me but a number of
00:00:11
things that change it and the problem
00:00:14
is with us again that what you can see
00:00:16
the officer. So I don't know what some
00:00:17
of you. only yesterday but your
00:00:19
attribute some newbie later And so he's
00:00:22
here without any will share some of
00:00:24
ease of use and ideas of why now Nestle
00:00:27
as a marketing to this journey from the
00:00:30
largest whatever's comparing into a
00:00:33
leaving or deleting present company.
00:00:36
Thank you very much. For being with us
00:00:38
real I have yeah ambassador in Belgium
00:00:41
excellency erected thank you very much
00:00:44
for being with us we on a by your
00:00:46
presence and I am sure that you have
00:00:48
enjoyed the demonstration at erica's
00:00:51
don't know what I try to explain to
00:00:53
people almost every day that's science
00:00:55
is a serious matter don't by serious
00:00:57
people No no no no so these things that
00:01:03
I will be quite short and and of course
00:01:05
intervention I believe time permitting
00:01:08
for you will engage in a brief question
00:01:09
and answer with the audience as well.
00:01:11
And other and Thomas would take the
00:01:13
floor again to give you some logistic
00:01:15
information. So I feel it was a
00:01:19
beautiful meeting it was only a good
00:01:22
meeting it was a beautiful meeting
00:01:24
would beautiful people beautiful mine
00:01:26
great ideas of the ancient we had
00:01:28
almost everything. We had some tension
00:01:31
of passion up some challenges what what
00:01:35
we stammers. So sometimes the speakers
00:01:38
that actually contributed a lot to the
00:01:40
quality of the discussion that I think
00:01:42
was missing was a flight of the oh
00:01:45
about the security of body but cold in
00:01:47
the middle of the night saying that
00:01:49
well distinguish speakers was going up
00:01:52
and down the stairs in PJ no no not
00:01:56
because yeah because you have forgotten
00:01:58
what is room was but because it was
00:02:01
trying to locate a crazy person that
00:02:03
was playing piano oh a unfortunately he
00:02:08
did find the person any turn out to be
00:02:10
another distinguish speaker from this
00:02:11
estimate. But in the multi separate
00:02:14
from I want distinguish people will be
00:02:15
a different accounts I have one I will
00:02:24
not tell the name but every everything
00:02:27
is negotiable including the tiny will
00:02:28
take for this bill to going to you too
00:02:30
I so yeah I don't want to get a sense
00:02:41
of you more that then irrigate decides
00:02:43
is not exactly this but so I agree I I
00:02:46
will not yeah but I would just share
00:02:48
with you what many of you bumping into
00:02:51
me at the coffee break said about the
00:02:53
first and the second that so the first
00:02:55
creating impress a lot when it came to
00:02:58
the broad overview yesterday today and
00:03:01
tomorrow's technology and the call was
00:03:03
but what what if we stopped working.
00:03:06
And we just wait that the ultimate
00:03:08
technology arise so we would do the
00:03:09
right experiments and we get the right
00:03:11
answer however one this was being done
00:03:16
we also so some evidence and
00:03:18
opportunities including at the
00:03:20
molecular level for nutrition solutions
00:03:23
to contribute to bring only
00:03:25
opportunities that that I would like to
00:03:28
buy into go button technologies and
00:03:29
also to Richard a reference which was
00:03:33
very heartwarming for me of the work
00:03:36
that hundred market has been doing. And
00:03:39
if I go to technologies you have on the
00:03:41
left and in the middle to is a fantasy
00:03:45
related right. Now simulation might be
00:03:47
one of the ultimate technologies and
00:03:49
Richard you talked a lot about large
00:03:51
databases data mining here on the right
00:03:53
hand side you have something of these
00:03:55
about fifteen years old and says then
00:03:57
you will recognise this this come from
00:03:59
and remote buttons from your insecure
00:04:01
in there that was fifteen years ago to
00:04:03
suggest that maybe this is a green
00:04:05
fluorescent protein molecule
00:04:06
constitution we die in expressing
00:04:09
primary you're enjoying that only wrote
00:04:11
going small. But that's not
00:04:13
informations at least in semantic
00:04:16
formed in vitro also do which is what
00:04:18
every colluded to what and and you see
00:04:20
the you know the right hand side so
00:04:22
well what on this actually became clear
00:04:26
to a few of us we went back to slide
00:04:28
that I show that the same council last
00:04:32
year at this is the work of these two
00:04:34
gentlemen that did not have those
00:04:36
technologies you have commuter go on
00:04:37
the left about this thing in the middle
00:04:40
in San Diego to Monica have what did
00:04:42
remarkable things and I I think
00:04:44
experiencing mother need a few years
00:04:46
ago what it looks like to go down his
00:04:48
microscope and look at those
00:04:50
preparation. And I don't know what
00:04:53
miracle he was able to use from the
00:04:55
picture on the left hand side that the
00:04:57
what graphical. And that's how we
00:04:59
describe a concentration of proper as
00:05:02
of cortical for and now we omnipoint
00:05:05
movement never saw the movements. And
00:05:09
squeezing chemical sensitive. And
00:05:12
mortal forces to circumvent obstacles
00:05:15
we call that imagination intuition but
00:05:17
maybe that also tells us that the
00:05:19
technology we have today is that use
00:05:21
proper can give us bigger inside the
00:05:24
ones we develop for them or now on the
00:05:27
till it was all the most exciting
00:05:30
especially for my nest like calling
00:05:32
because we went through a series of
00:05:34
very for metabolic pathways Monica
00:05:37
pathways signal transduction in the
00:05:38
cells we have yeah we have pristine.
00:05:41
But why christian when you show this
00:05:44
right that leaves on the left hand side
00:05:47
of the box. And goes on the right
00:05:49
inside gets a shock and leaves you said
00:05:52
that they remember that there is
00:05:54
something like for sure but then
00:05:55
somebody ask a question. And you said
00:05:57
that some of those routes actually go
00:05:58
back to see whether they're gonna get
00:06:01
another show it understand well what
00:06:03
whatever the molecular mechanism this
00:06:05
incomprehensible behaviour is it
00:06:07
explains the behaviour of old chief
00:06:09
technology officer yeah back in the
00:06:14
office of the chief executive officer I
00:06:17
we also so the major challenges that I
00:06:23
can still address sometimes disease
00:06:25
would single products which is what the
00:06:27
firemen industries bound to do almost
00:06:29
by definition one comes to the real the
00:06:31
framework that they operate within. And
00:06:34
that led rapping about what we have for
00:06:37
doing those two days to the option at
00:06:40
least in my mind and I take the blame
00:06:42
you this is not just to be appropriate
00:06:44
then combinatorial approaches will have
00:06:47
to be designed you know to to address a
00:06:49
disease that that so much difficult
00:06:52
like to mechanism underlying it. And
00:06:55
maybe something different phenotype. So
00:06:57
to me if I go back to Rebecca remember
00:06:59
that were younger speaker which start
00:07:01
at the top by saying I have nothing to
00:07:03
do with nutrition but maybe you realise
00:07:04
that she only talked about nutrition to
00:07:07
talk about sound which is a sure but
00:07:09
the but in the and I think she
00:07:11
highlighted the fact that we have with
00:07:14
nutrition with for a very special
00:07:16
emotional relationship. And the
00:07:19
gentleman that will follow well
00:07:21
actually value all of this much better
00:07:22
than me but I and ready to ask you
00:07:26
going back to Rebecca scale what would
00:07:28
you like to put your if I ask to know
00:07:31
that years from now there will be
00:07:35
nutritional solutions that would be
00:07:37
considered very seriously as part of a
00:07:39
combinatorial approach to address
00:07:41
sometimes disease. What you put your
00:07:43
well all I I just before yeah you said
00:07:50
that ladies and gentlemen a personal
00:07:53
runs our ship on a daily basis is
00:07:56
probable KIM only have four mister
00:07:59
research grateful and honoured that you
00:08:01
are willing to come here these people
00:08:03
would you like to comment address the

Share this talk: 


Conference Program

Introduction to the 12th Nestlé International Nutrition Symposium
Thomas Beck, NRC Director
22 Oct. 2015 · 8:57 a.m.
418 views
Introduction to Session I - Cognitive & Brain Development
Susan Gasser, Friedrich Miescher Institute, Basel, Switzerland
22 Oct. 2015 · 9:04 a.m.
The development of a healthy brain
Michael Gazzaniga, University of California, Santa Barbara, USA
22 Oct. 2015 · 9:16 a.m.
221 views
Q&A - The development of a healthy brain
Michael Gazzaniga, University of California, Santa Barbara, USA
22 Oct. 2015 · 9:56 a.m.
Early influences on brain development and epigenetics
Stephen G. Matthews, University of Toronto, Canada
22 Oct. 2015 · 10:49 a.m.
Q&A - Early influences on brain development and epigenetics
Stephen G. Matthews, University of Toronto, Canada
22 Oct. 2015 · 11:29 a.m.
Building the physiology of thought
Rebecca Saxe, Massachusetts Institute of Technology, Cambridge, USA
22 Oct. 2015 · 11:38 a.m.
154 views
Q&A - Building the physiology of thought
Rebecca Saxe, Massachusetts Institute of Technology, Cambridge, USA
22 Oct. 2015 · 12:10 p.m.
Introduction to Session II - Cognitive Decline
Kathinka Evers
22 Oct. 2015 · 2:02 p.m.
Brain health & brain diseases - future perspectives
Richard Frackowiak, CHUV University Hospital, Lausanne, Switzerland
22 Oct. 2015 · 2:11 p.m.
Alzheimer's disease: genome-wide clues for novel therapies
Rudolph E. Tanzi, Massachusetts General Hospital, Charlestown, USA
22 Oct. 2015 · 3:15 p.m.
Q&A - Alzheimer's disease: genome-wide clues for novel therapies
Rudolph E. Tanzi, Massachusetts General Hospital, Charlestown, USA
22 Oct. 2015 · 3:59 p.m.
Immunometabolic regulators of age-related inflammation
Vishwa D. Dixit, Yale School of Medicine, New Haven, USA
22 Oct. 2015 · 4:21 p.m.
Q&A - Immunometabolic regulators of age-related inflammation
Vishwa D. Dixit, Yale School of Medicine, New Haven, USA
22 Oct. 2015 · 4:59 p.m.
Introduction to Session III - Nutrition & Cognitive Development
Pierre Magistretti, KAUST, Thuwal, Saudi Arabia and EPFL, Lausanne, Switzerland
23 Oct. 2015 · 9 a.m.
Energy metabolism in long-term memory formation and enhancement
Cristina M. Alberini, The Center for Neural Science, New York University, USA
23 Oct. 2015 · 9:16 a.m.
129 views
Q&A - Energy metabolism in long-term memory formation and enhancement
Cristina M. Alberini, The Center for Neural Science, New York University, USA
23 Oct. 2015 · 9:53 a.m.
Building the costly human brain: implications for the evolution of slow childhood growth and the origins of diabetes
Christopher Kuzawa, Northwestern University, Evanston, USA
23 Oct. 2015 · 10:29 a.m.
Q&A - Building the costly human brain: implications for the evolution of slow childhood growth and the origins of diabetes
Christopher Kuzawa, Northwestern University, Evanston, USA
23 Oct. 2015 · 10:57 a.m.
Nutrition, growth and the developing brain
Prof. Maureen Black, University of Maryland, School of Medicine, Baltimore, USA
23 Oct. 2015 · 11:09 a.m.
Q&A - Nutrition, growth and the developing brain
Prof. Maureen Black, University of Maryland, School of Medicine, Baltimore, USA
23 Oct. 2015 · 11:49 a.m.
Introduction to Session IV - Decline & Nutritional Intervention
Tamas Bartfai, The Scripps Research Institute, La Jolla, USA
23 Oct. 2015 · 12:48 p.m.
On multi-domain approaches for prevention trials
Miia Kivipelto, Karolinska Institutet, Stockholm, Sweden
23 Oct. 2015 · 1:04 p.m.
Q&A - On multi-domain approaches for prevention trials
Miia Kivipelto, MD, PhD, Karolinska Institutet
23 Oct. 2015 · 1:39 p.m.
Methodological challenges in Alzheimer clinical development
Lon S. Schneider, Keck School of Medicine of USC, Los Angeles, USA
23 Oct. 2015 · 1:49 p.m.
Q&A - Methodological challenges in Alzheimer clinical development
Lon S. Schneider, Keck School of Medicine of USC, Los Angeles, USA
23 Oct. 2015 · 2:32 p.m.
We are what we remember: memory and age related memory disorders
Eric R. Kandel, Columbia University, New York, USA
23 Oct. 2015 · 3:03 p.m.
138 views
Concluding Remarks
Stefan Catsicas, Chief Technology Officer, Nestlé SA
23 Oct. 2015 · 3:50 p.m.

Recommended talks

Q&A : Fecal transplant to mine for novel probiotics
Max Nieuwdorp, Amsterdam Medical Center, The Netherlands
24 Oct. 2014 · 11:25 a.m.